Arlix A et al. – The long–term clinical and imaging follow–up indicated that none of the patients with branch duct (BD)BD–intraductal papillary mucinous neoplasms (IPMNs) developed malignancy. Therefore, BD–IPMNs with no signs of malignancy should be managed conservatively. The authors propose that following a 2–year patient follow–up, biannual imaging follow–ups could be sufficient. [more...]